Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BMO Capital Markets started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research note released on Monday morning, The Fly reports. The brokerage issued an outperform rating and a $18.00 target price on the stock. Several other equities analysts have also recently weighed in on the stock. JPMorgan Chase & Co. […]
Monashee Investment Management LLC bought a new stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 122,500 shares of the company’s stock, valued at approximately $1,247,000. Monashee Investment Management LLC owned 0.33% of Terns Pharmaceuticals at […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) hit a new 52-week high on Wednesday . The stock traded as high as $13.06 and last traded at $13.02, with a volume of 182770 shares changing hands. The stock had previously closed at $12.09. Wall Street Analyst Weigh In Several equities analysts have recently weighed in on […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating)’s share price traded up 4.9% during trading on Thursday . The stock traded as high as $11.66 and last traded at $11.57. 277,276 shares were traded during mid-day trading, a decline of 17% from the average session volume of 332,730 shares. The stock had previously closed at $11.03. […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its price objective hoisted by HC Wainwright from $7.00 to $11.00 in a research report released on Wednesday morning, The Fly reports. HC Wainwright currently has a neutral rating on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q1 2023 earnings at ($0.30) EPS, Q2 2023 […]